The 447 truncation of lipoprotein lipase, lipids and lipoproteins, and risk of ischaemic heart disease.: The Copenhagen City Heart Study and updated meta-analyses

被引：0
|
作者：
Wittrup, H
Nordestgaard, BG
Steffensen, R
Jensen, G
Tybjæerg-Hansen, A
机构：
[1] Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark
[4] Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3312
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [41] Hypercholesterolemia and the risk of ischemic heart disease in individuals with mutations causing familial defective apolipoprotein B100. The Copenhagen City Heart Study
    TybjaergHansen, A
    Steffensen, R
    Meinertz, H
    Schnohr, P
    Nordestgaard, BG
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 74 - 74
  • [42] Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study
    Chen, W
    Srinivasan, SR
    Elkasabany, A
    Ellsworth, DL
    Boerwinkle, E
    Berenson, GS
    ATHEROSCLEROSIS, 2001, 159 (02) : 367 - 373
  • [43] Triglycerides, High-Density Lipoprotein Cholesterol, and Risk of Ischemic Heart Disease: A View from the Copenhagen Male Study
    Jeppesen, Jorgen
    METABOLIC SYNDROME AND RELATED DISORDERS, 2003, 1 (01) : 33 - 53
  • [44] Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: The Bogalusa Heart Study
    Chen, W
    Srinivasan, SR
    Hallman, MD
    Elkasabany, AM
    Boerwinkle, E
    Ellsworth, D
    Berenson, GS
    CIRCULATION, 2000, 102 (18) : 31 - 31
  • [45] Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids
    van Bockxmeer, FM
    Liu, QH
    Mamotte, C
    Burke, V
    Taylor, R
    ATHEROSCLEROSIS, 2001, 157 (01) : 123 - 129
  • [46] Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
    Kaptoge, Stephen
    Seshasai, Sreenivasa Rao Kondapally
    Gao, Pei
    Freitag, Daniel F.
    Butterworth, Adam S.
    Borglykke, Anders
    Di Angelantonio, Emanuele
    Gudnason, Vilmundur
    Rumley, Ann
    Lowe, Gordon D. O.
    Jorgensen, Torben
    Danesh, John
    EUROPEAN HEART JOURNAL, 2014, 35 (09) : 578 - U35
  • [47] Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease -: The Copenhagen City Heart Study
    Agerholm-Larsen, B
    Tybjærg-Hansen, A
    Schnohr, P
    Steffensen, R
    Nordestgaard, BG
    CIRCULATION, 2000, 102 (18) : 2197 - 2203
  • [48] Lipoprotein(a) predicts fatal but not non-fatal cardiovascular events: The Kuopio Ischaemic Heart Disease Risk Factor Study
    Nyyssonen, K
    Laukkanen, J
    Tuomainen, TP
    Salonen, JT
    CIRCULATION, 2002, 106 (19) : 729 - 729
  • [49] Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A α1-antitrypsin -: Carriers of the Copenhagen City Heart Study
    Dahl, M
    Tybjærg-Hansen, A
    Nordestgaard, BG
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (11)
  • [50] Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease - Six case-control studies from the Copenhagen City Heart Study
    Sethi, AA
    Tybjaerg-Hansen, A
    Gronholdt, MLM
    Steffensen, R
    Schnohr, P
    Nordestgaard, BG
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (10) : 941 - 954
12345